Literature DB >> 2315239

Heparin-induced hyperkalemia.

T E Edes1.   

Abstract

Heparin sodium is an extremely useful medication with demonstrated benefit in a number of clinical settings. Physicians need to be aware of the potential complication of hyperkalemia, especially in patients with renal insufficiency or diabetes mellitus. Discontinuation of heparin therapy is necessary to reverse the suppression of aldosterone. If heparin is the cause, the hyperkalemia will resolve within 5 days.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315239     DOI: 10.1080/00325481.1990.11704598

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels.

Authors:  Girish M Bengalorkar; N Sarala; P N Venkatrathnamma; T N Kumar
Journal:  J Pharmacol Pharmacother       Date:  2011-10

2.  The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Authors:  Davina J Tai; Kelvin Leung; Pietro Ravani; Robert R Quinn; Nairne Scott-Douglas; Jennifer M MacRae
Journal:  BMC Nephrol       Date:  2015-08-25       Impact factor: 2.388

3.  Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.

Authors:  Nima Melzer; Peter Bramlage; Hans-Christoph Michaelis
Journal:  BMC Res Notes       Date:  2014-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.